Preclinical studies for the combination of paclitaxel and curcumin in cancer therapy

Y Wei, X Pu, L Zhao - Oncology reports, 2017 - spandidos-publications.com
Cancer is one of the most common causes of death and remains the first in China and the
second in the US. The common treatments for cancer include surgery, radiation …

[图书][B] Encyclopedia of Polymer Applications, 3 Volume Set

M Mishra - 2018 - taylorfrancis.com
Undoubtedly the applications of polymers are rapidly evolving. Technology is continually
changing and quickly advancing as polymers are needed to solve a variety of day-to-day …

Regulation of carcinogenesis and modulation through Wnt/β-catenin signaling by curcumin in an ovarian cancer cell line

HY Yen, CW Tsao, YW Lin, CC Kuo, CH Tsao… - Scientific reports, 2019 - nature.com
The secreted frizzled-related protein 5 gene (SFRP5) that antagonize the Wnt/β-catenin
signaling is frequently inactivated by promoter methylation and oncogenic activation of the …

Molecular targets of curcumin and its therapeutic potential for ovarian cancer

M Mohamadian, A Bahrami, M Moradi Binabaj… - Nutrition and …, 2022 - Taylor & Francis
Ovarian cancer is the fifth most common gynecological cancer in women globally.
Conventional chemotherapy is the first therapeutic approach in the treatment of ovarian …

Curcumin reverses doxorubicin resistance in colon cancer cells at the metabolic level

N Zhang, M Gao, Z Wang, J Zhang, W Cui, J Li… - … of pharmaceutical and …, 2021 - Elsevier
Doxorubicin (Dox) is commonly used for the treatment of malignant tumors, including colon
cancer. However, the development of P-glycoprotein (P-gp)-mediated multidrug resistance …

The therapeutic potential of common herbal and nano-based herbal formulations against ovarian cancer: New insight into the current evidence

F Rezaei-Tazangi, H Roghani-Shahraki… - Pharmaceuticals, 2021 - mdpi.com
Ovarian cancer (OCa) is characterized as one of the common reasons for cancer-associated
death in women globally. This gynecological disorder is chiefly named the “silent killer” due …

Curcumin loaded selenium nanoparticles synergize the anticancer potential of doxorubicin contained in self-assembled, cell receptor targeted nanoparticles

M Kumari, MP Purohit, S Patnaik, Y Shukla… - European Journal of …, 2018 - Elsevier
Doxorubicin (DOX) has been extensively used to treat a wide range of cancers in free and
nanotized form. Nanotization of DOX has alleviated its toxicity and efflux-mediated …

Albumin nanoparticles with synergistic antitumor efficacy against metastatic lung cancers

B Kim, B Seo, S Park, C Lee, JO Kim, KT Oh… - Colloids and Surfaces B …, 2017 - Elsevier
Albumin nanoparticles are well-known as effective drug carriers used to deliver hydrophobic
chemotherapeutic agents. Albumin nanoparticles encapsulating curcumin and doxorubicin …

Curcumin enhances the anti-cancer efficacy of paclitaxel in ovarian cancer by regulating the miR-9-5p/BRCA1 axis

Y Liu, Z Shen, T Zhu, W Lu, Y Fu - Frontiers in Pharmacology, 2023 - frontiersin.org
Background: Patients with late-stage ovarian cancer still have a very poor prognosis due to
chemotherapy resistance. Curcumin has been shown to synergistically enhance the …

Carrier‐Free Nanoassembly of Curcumin–Erlotinib Conjugate for Cancer Targeted Therapy

C Cheng, B Sui, M Wang, X Hu… - Advanced healthcare …, 2020 - Wiley Online Library
Anticancer drug‐loaded nanoparticles have been explored extensively to decrease side
effects while improving their therapeutic efficacy. However, due to the low drug loading …